SE8403630D0 - Humana proteiner - Google Patents

Humana proteiner

Info

Publication number
SE8403630D0
SE8403630D0 SE8403630A SE8403630A SE8403630D0 SE 8403630 D0 SE8403630 D0 SE 8403630D0 SE 8403630 A SE8403630 A SE 8403630A SE 8403630 A SE8403630 A SE 8403630A SE 8403630 D0 SE8403630 D0 SE 8403630D0
Authority
SE
Sweden
Prior art keywords
proteins
antisera
humana
methods
determinatoin
Prior art date
Application number
SE8403630A
Other languages
English (en)
Other versions
SE8403630L (sv
SE500219C2 (sv
Inventor
M Fagerhol
I Dale
I Naesgaard
Original Assignee
Ciba Geigy Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ciba Geigy Ag filed Critical Ciba Geigy Ag
Publication of SE8403630D0 publication Critical patent/SE8403630D0/sv
Publication of SE8403630L publication Critical patent/SE8403630L/sv
Publication of SE500219C2 publication Critical patent/SE500219C2/sv

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/574—Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • G01N33/57484—Immunoassay; Biospecific binding assay; Materials therefor for cancer involving compounds serving as markers for tumor, cancer, neoplasia, e.g. cellular determinants, receptors, heat shock/stress proteins, A-protein, oligosaccharides, metabolites
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
    • G01N33/56966—Animal cells
    • G01N33/56972—White blood cells
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/574—Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • G01N33/57407—Specifically defined cancers
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/574—Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • G01N33/57407—Specifically defined cancers
    • G01N33/57426—Specifically defined cancers leukemia
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6893—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to diseases not provided for elsewhere
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S435/00—Chemistry: molecular biology and microbiology
    • Y10S435/803—Physical recovery methods, e.g. chromatography, grinding
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S435/00—Chemistry: molecular biology and microbiology
    • Y10S435/81—Packaged device or kit
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S436/00—Chemistry: analytical and immunological testing
    • Y10S436/807—Apparatus included in process claim, e.g. physical support structures
    • Y10S436/808—Automated or kit
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S530/00—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
    • Y10S530/806—Antigenic peptides or proteins
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S530/00—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
    • Y10S530/827—Proteins from mammals or birds

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Hematology (AREA)
  • Molecular Biology (AREA)
  • Chemical & Material Sciences (AREA)
  • Biomedical Technology (AREA)
  • Urology & Nephrology (AREA)
  • Cell Biology (AREA)
  • Food Science & Technology (AREA)
  • Pathology (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • General Physics & Mathematics (AREA)
  • Medicinal Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Hospice & Palliative Care (AREA)
  • Oncology (AREA)
  • Zoology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Virology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
SE8403630A 1983-07-11 1984-07-09 Humana granulocytproteiner SE500219C2 (sv)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB838318754A GB8318754D0 (en) 1983-07-11 1983-07-11 Human proteins anti-sera test kits

Publications (3)

Publication Number Publication Date
SE8403630D0 true SE8403630D0 (sv) 1984-07-09
SE8403630L SE8403630L (sv) 1985-01-12
SE500219C2 SE500219C2 (sv) 1994-05-09

Family

ID=10545560

Family Applications (1)

Application Number Title Priority Date Filing Date
SE8403630A SE500219C2 (sv) 1983-07-11 1984-07-09 Humana granulocytproteiner

Country Status (11)

Country Link
US (1) US4833074A (sv)
JP (2) JPH0784479B2 (sv)
BE (1) BE900119A (sv)
CH (1) CH661048A5 (sv)
DE (1) DE3425186C2 (sv)
DK (1) DK169439B1 (sv)
FR (1) FR2550205B1 (sv)
GB (2) GB8318754D0 (sv)
IT (1) IT1177889B (sv)
NL (1) NL192456C (sv)
SE (1) SE500219C2 (sv)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0263072B1 (en) * 1986-10-03 1994-03-23 Ciba-Geigy Ag Novel lymphokine related peptides
JPH023698A (ja) * 1988-06-20 1990-01-09 Denki Kagaku Kogyo Kk ヒトリンホトキシンに対するモノクローナル抗体及びそれら抗体を産生するハイブリドーマ、並びにそれら抗体を用いたヒトリンホトキシンの精製方法、測定方法及び測定試薬
US5211937A (en) * 1990-07-30 1993-05-18 Glycomed Incorporated Method of determining a site of inflammation utilizing elam-1 ligands
US5776348A (en) * 1995-02-07 1998-07-07 Massachusetts Institute Of Technology Mineral precipitation system and method for inhibiting mineral precipitate formation
ATE278964T1 (de) 1996-11-01 2004-10-15 Magne K Fagerhol Verfahren zur proteinextraktion
ZA981370B (en) * 1997-02-20 1998-09-07 Cerberus Developments Bv Method and apparatus for continuous flow isoelectric focusing for purifying biological substances
DK1100828T3 (da) * 1998-07-22 2008-07-21 Sapporo Breweries Fremgangsmåder til fremstilling af antistoffer mod mælkesyrebakterier der fordærver öl, og diagnostisk anvendelse deraf
GB0229747D0 (en) * 2002-12-20 2003-01-29 Axis Shield Asa Assay
EP1608397B1 (en) 2003-03-28 2008-10-15 Universite Laval S100 protein as neutrophil activator for alleviating neutropenia in cancer treatment
BRPI0513740A (pt) * 2004-07-23 2008-05-13 Aspenbio Pharma Inc método e dispositivo para o diagnóstico de apendicite
US7659087B2 (en) * 2004-07-23 2010-02-09 Aspenbio Pharma, Inc. Methods and devices for diagnosis of appendicitis
US20110212104A1 (en) * 2008-11-03 2011-09-01 Schering Corporation Inflammatory bowel disease biomarkers and related methods of treatment
JP5883849B2 (ja) * 2010-04-29 2016-03-15 バクスター・インターナショナル・インコーポレイテッドＢａｘｔｅｒ Ｉｎｔｅｒｎａｔｉｏｎａｌ Ｉｎｃｏｒｐ０Ｒａｔｅｄ 陰イオン交換樹脂を用いる二価カチオン結合タンパク質の精製方法
CN108290058B (zh) 2015-09-17 2023-05-16 美国安进公司 使用il23途径生物标志物预测il23拮抗剂的临床应答
JP2019508370A (ja) 2015-12-22 2019-03-28 アムジェン インコーポレイテッド Ｉｌ２３アンタゴニストに対する臨床応答の予測因子としてのｃｃｌ２０
US11714082B2 (en) 2017-05-09 2023-08-01 Immundiagnostik Ag Method for determination of members of the S100 family of calcium binding proteins by immunoturbidimetry

Also Published As

Publication number Publication date
NL192456B (nl) 1997-04-01
US4833074A (en) 1989-05-23
FR2550205A1 (fr) 1985-02-08
DK169439B1 (da) 1994-10-31
IT8448540A0 (it) 1984-07-10
SE8403630L (sv) 1985-01-12
GB2143239A (en) 1985-02-06
GB8417338D0 (en) 1984-08-08
SE500219C2 (sv) 1994-05-09
BE900119A (fr) 1985-01-09
NL192456C (nl) 1997-08-04
JP2558442B2 (ja) 1996-11-27
GB8318754D0 (en) 1983-08-10
NL8402182A (nl) 1985-02-01
FR2550205B1 (fr) 1989-12-08
JPH07278194A (ja) 1995-10-24
IT1177889B (it) 1987-08-26
DE3425186A1 (de) 1985-01-24
JPS6051113A (ja) 1985-03-22
DK338484D0 (da) 1984-07-10
CH661048A5 (de) 1987-06-30
JPH0784479B2 (ja) 1995-09-13
DK338484A (da) 1985-01-12
GB2143239B (en) 1987-11-11
DE3425186C2 (de) 1995-04-20

Similar Documents

Publication Publication Date Title
SE8403630L (sv) Humana proteiner
ES520985A0 (es) Procedimiento para la preparacion de nuevos 6,11-dihidrodibenzo (b,e)-tiepin-11-n-alcohilnorescopin-eteres cuaternarios.
DK173883D0 (da) Substituerede 8-phenylxanthiner
ES2036737T3 (es) Procedimiento para la obtencion de mezclas farmaceuticas.
PT804196E (pt) Utilizacao de antagonistas de serotonina (5ht3) para o tratamento de fibromialgia
ES529698A0 (es) Procedimiento para la produccion de proteinas correlacionadas con la toxina difterica
ATA328286A (de) Zell-linien und verfahren zur herstellung von humanen monoklonalen antikörpern sowie kit und verfahren zur bestimmung der anwesenheit von p.aeruginosa
NO851928L (no) Fremgangsmaate til fremstilling av glyserofosfocholin- og glyserofosfoetanolaminderivater og anvendelse derav.
ES501195A0 (es) Procedimiento para la preparacion de imidosulfamidas antia- lergicas
AR221174A1 (es) Procedimiento para la descarbonatacion de gases
IT8019095A0 (it) Procedimento e installazione per la fabbricazione di clincher di cementeria.
ES492821A0 (es) Procedimiento para la obtencion de derivados de 2-hidroxime-til-3,4,5-trihidroxipiperidinas
ES519690A0 (es) Procedimiento para la obtencion de azolil-fenoxi-tetrahidrofuran-2-iliden-metanos.
ES492143A0 (es) Procedimiento para la obtencion de derivados de 3,4,5-trihi-droxipiperidina
FI844645L (fi) 1,7-difenyl-3-metylaza-7-cyan-8 -metyl-nonan foer anvaendning vid bekaempning av sjukdomar.
ES503993A0 (es) Procedimiento para la produccion de pentapeptidos
IT1163492B (it) Procedimento per la concia delle pelli
ES520599A0 (es) Procedimiento para la obtencion de fenoxipropiltriazolil-cetonas y carbinoles.
ES488301A0 (es) Procedimiento para la obtencion de dehidropeptidos
ES537875A0 (es) Procedimiento para la obtencion de macromeros poliamidas
ES533775A0 (es) Procedimiento para la fabricacion de aleaciones de ferrosilicio o de silicio, que contienen estroncio
ATE98491T1 (de) Verwendung von antigestagenen zur herstellung von arzneimitteln.
ES532015A0 (es) Procedimiento para la obtencion de fenoxitriazolil-cetonas y carbinoles
ES502033A0 (es) Procedimiento para la obtencion de imidazolil-indeno-tiofe- nos
ES530041A0 (es) Procedimiento para la obtencion de oxaspirododecan-derivados de efecto perfumante

Legal Events

Date Code Title Description
NUG Patent has lapsed